Skip to main content
padlock icon - secure page this page is secure

THE EFFECTS OF INCREASED ACCESS TO EMERGENCY CONTRACEPTION ON SEXUALLY TRANSMITTED DISEASE AND ABORTION RATES

Buy Article:

$52.00 + tax (Refund Policy)

In 2006, the Food and Drug Administration (FDA) approved access to emergency contraception through pharmacies without a prescription. Several states, however, had previously allowed pharmacy access to emergency contraception. In particular, Washington State was the first state to implement such a program in 1998. If emergency contraception is used as a substitute for a surgical abortion, then pharmacy access could reduce unintended pregnancy. Pharmacy access, however, could lead to an increase in risk taking, especially among teens or young adults, and hence lead to increased rates of sexually transmitted diseases. In this article, we use county‐level data as well as specific timing of changes in pharmacy access to consider the intended and unintended consequences of pharmacy access to emergency contraception in Washington. The results indicate that while county‐level access to emergency contraception was unrelated to trends in sexually transmitted diseases (STDs) and abortions before access changed, access afterwards led to a statistically significant increase in STD rates (gonorrhea rates), both overall and for females. We do not find, however, an impact of pharmacy access on abortion or birth rates. These results are robust to several specification tests (including use of Oregon counties as additional control counties) as well as several falsification tests. (JEL I1, I18, J13)
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Department of Public Policy, University of North Carolina, 203 Abernethy Hall, Campus Box 3435, Chapel Hill, NC 27599-3435. Phone 919-962-0692, Fax: 919-962-5824

Publication date: July 1, 2013

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more